Skip to content
Application 217217
- Type
- ANDA
- Sponsor
- BIOCON PHARMA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DASATINIB | DASATINIB | TABLET;ORAL | 20MG | No | No |
| 002 | DASATINIB | DASATINIB | TABLET;ORAL | 50MG | No | No |
| 003 | DASATINIB | DASATINIB | TABLET;ORAL | 70MG | No | No |
| 004 | DASATINIB | DASATINIB | TABLET;ORAL | 80MG | No | No |
| 005 | DASATINIB | DASATINIB | TABLET;ORAL | 100MG | No | No |
| 006 | DASATINIB | DASATINIB | TABLET;ORAL | 140MG | No | No |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 77745 | ORIG | 2024-03-07 |